Concepedia

Lanxin Liu

LL

9

Publications

352

Citations

9

H-Index

2015

Active since

Affiliations

The Barbara Ann Karmanos Cancer Institute(Current)

Wayne State University

Jilin University

Hebei University of Chinese Medicine

Lanxin Liu is an author at The Barbara Ann Karmanos Cancer Institute specializing in medicine, gene expression, and cancer research.

ORCID

Top concepts

Publications per year

2015–2021

9

Publications

9

HDAC2 overexpression correlates with aggressive clinicopathological features and DNA-damage response pathway of breast cancer.

Wenqi Shan, Yuanyuan Jiang, Huimei Yu et al. · PubMed · 2017 · 70 citations · Full text

Multi-omics integration of methyltransferase-like protein family reveals clinical outcomes and functional signatures in human cancer

Ion John Campeanu, Yuanyuan Jiang, Lanxin Liu et al. · Scientific Reports · 2021 · 57 citations · Full text

Integrated genomic and functional analyses of histone demethylases identify oncogenic KDM2A isoform in breast cancer

Hui Liu, Lanxin Liu, Andreana Holowatyj et al. · Molecular Carcinogenesis · 2015 · 47 citations · Full text

Pan-cancer analysis of RNA methyltransferases identifies FTSJ3 as a potential regulator of breast cancer progression

Morenci Manning, Yuanyuan Jiang, Rui Wang et al. · RNA Biology · 2020 · 43 citations · Full text

Structural analysis, virtual screening and molecular simulation to identify potential inhibitors targeting 2'-O-ribose methyltransferase of SARS-CoV-2 coronavirus

Yuanyuan Jiang, Lanxin Liu, Morenci Manning et al. · Journal of Biomolecular Structure and Dynamics · 2020 · 38 citations · Full text

Rows per page

1–5 of 9